How Is Mesothelioma Diagnosed?

Quick Answer

Mesothelioma diagnosis requires multiple steps: (1) imaging (chest/abdominal CT, PET scan), (2) fluid analysis if effusion present (thoracentesis or paracentesis), (3) tissue biopsy (gold standard — required for definitive diagnosis), (4) immunohistochemistry to identify cell type and rule out other cancers, (5) staging (TNM system). Process typically takes 4-8 weeks from initial symptom presentation.

Mesothelioma diagnosis requires multiple confirmatory steps because mesothelioma cells are difficult to distinguish from other cancers (especially adenocarcinoma) without immunohistochemistry. The diagnostic process typically takes 4-8 weeks.

Step 1: Initial Imaging

Chest CT scan (for pleural mesothelioma) or abdominal CT (for peritoneal). PET-CT may be added to identify metastatic spread.

Step 2: Fluid Analysis (if effusion present)

**Thoracentesis** (chest fluid drainage) for pleural cases or **paracentesis** (abdominal fluid drainage) for peritoneal cases. The fluid is sent for cytology — but cytology alone is rarely diagnostic for mesothelioma.

Step 3: Tissue Biopsy (Gold Standard)

Definitive mesothelioma diagnosis requires tissue biopsy. Methods include: video-assisted thoracoscopic surgery (VATS) biopsy, CT-guided needle biopsy, surgical (open) biopsy, or laparoscopy for peritoneal cases.

Step 4: Immunohistochemistry (IHC)

Tissue samples undergo immunohistochemistry staining to identify mesothelioma cells vs other cancers. Mesothelioma markers include: calretinin (positive), WT-1 (positive), CK5/6 (positive), D2-40/podoplanin (positive), CEA (negative — distinguishes from adenocarcinoma), MOC-31 (negative). Cell type (epithelioid, sarcomatoid, biphasic) is also identified at this stage.

Step 5: Staging

Mesothelioma staging uses the TNM system (Tumor / Node / Metastasis) to determine treatment options and prognosis. Stages I-IV correlate with treatment options and survival.